Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

Geert C. van Almen; Melissa Swinnen; Paolo Carai; Wouter Verhesen; Jack P. M. Cleutjens; Jan D'hooge; Fons K. Verheyen; Yigal M. Pinto; Blanche Schroen; Peter Carmeliet; Stephane Heymans

doi:10.1016/j.yjmcc.2011.05.010

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

Geert C. van Almen, Melissa Swinnen, Paolo Carai, Wouter Verhesen, Jack P. M. Cleutjens, Jan D'hooge, Fons K. Verheyen, Yigal M. Pinto, Blanche Schroen, Peter Carmeliet, Stephane Heymans

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	318-328
Journal	Journal of Molecular and Cellular Cardiology
Volume	51
Issue number	3
DOIs	https://doi.org/10.1016/j.yjmcc.2011.05.010
Publication status	Published - Sep 2011

Keywords

Akt
Cardiomyopathy
Doxorubicin
Extracellular matrix
Thrombospondin-2

Access to Document

10.1016/j.yjmcc.2011.05.010

Cite this

van Almen, G. C., Swinnen, M., Carai, P., Verhesen, W., Cleutjens, J. P. M., D'hooge, J., Verheyen, F. K., Pinto, Y. M., Schroen, B., Carmeliet, P., & Heymans, S. (2011). Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. Journal of Molecular and Cellular Cardiology, 51(3), 318-328. https://doi.org/10.1016/j.yjmcc.2011.05.010

van Almen, Geert C. ; Swinnen, Melissa ; Carai, Paolo ; Verhesen, Wouter ; Cleutjens, Jack P. M. ; D'hooge, Jan ; Verheyen, Fons K. ; Pinto, Yigal M. ; Schroen, Blanche ; Carmeliet, Peter ; Heymans, Stephane. / Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. In: Journal of Molecular and Cellular Cardiology. 2011 ; Vol. 51, No. 3. pp. 318-328.

@article{2ada6a6bdb58433598374f9230d126e5,

title = "Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy",

keywords = "Akt, Cardiomyopathy, Doxorubicin, Extracellular matrix, Thrombospondin-2",

author = "{van Almen}, {Geert C.} and Melissa Swinnen and Paolo Carai and Wouter Verhesen and Cleutjens, {Jack P. M.} and Jan D'hooge and Verheyen, {Fons K.} and Pinto, {Yigal M.} and Blanche Schroen and Peter Carmeliet and Stephane Heymans",

year = "2011",

month = sep,

doi = "10.1016/j.yjmcc.2011.05.010",

language = "English",

volume = "51",

pages = "318--328",

journal = "Journal of Molecular and Cellular Cardiology",

issn = "0022-2828",

publisher = "ELSEVIER SCI LTD",

number = "3",

}

van Almen, GC, Swinnen, M, Carai, P, Verhesen, W, Cleutjens, JPM, D'hooge, J, Verheyen, FK, Pinto, YM, Schroen, B, Carmeliet, P & Heymans, S 2011, 'Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy', Journal of Molecular and Cellular Cardiology, vol. 51, no. 3, pp. 318-328. https://doi.org/10.1016/j.yjmcc.2011.05.010

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. / van Almen, Geert C.; Swinnen, Melissa; Carai, Paolo; Verhesen, Wouter; Cleutjens, Jack P. M.; D'hooge, Jan; Verheyen, Fons K.; Pinto, Yigal M.; Schroen, Blanche; Carmeliet, Peter; Heymans, Stephane.

In: Journal of Molecular and Cellular Cardiology, Vol. 51, No. 3, 09.2011, p. 318-328.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

AU - van Almen, Geert C.

AU - Swinnen, Melissa

AU - Carai, Paolo

AU - Verhesen, Wouter

AU - Cleutjens, Jack P. M.

AU - D'hooge, Jan

AU - Verheyen, Fons K.

AU - Pinto, Yigal M.

AU - Schroen, Blanche

AU - Carmeliet, Peter

AU - Heymans, Stephane

PY - 2011/9

Y1 - 2011/9

KW - Akt

KW - Cardiomyopathy

KW - Doxorubicin

KW - Extracellular matrix

KW - Thrombospondin-2

U2 - 10.1016/j.yjmcc.2011.05.010

DO - 10.1016/j.yjmcc.2011.05.010

M3 - Article

VL - 51

SP - 318

EP - 328

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 3

ER -